1990
DOI: 10.1016/0264-410x(90)90090-9
|View full text |Cite
|
Sign up to set email alerts
|

Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use. I. Efficacy and analysis of vaccine failures

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

1994
1994
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 12 publications
0
7
0
Order By: Relevance
“…On this basis, the rates of vaccination between 1974 and 2004 were reconstructed. Vaccine manufacturers or pharmacist associations were unable to provide any data on the annual quantity of vaccine sold from which a more precise rate of vaccination could have been calculated for the period between 1974 and 2004 [24][25][26][27][28][29][30][31][32][33][34].…”
Section: Methodsmentioning
confidence: 99%
“…On this basis, the rates of vaccination between 1974 and 2004 were reconstructed. Vaccine manufacturers or pharmacist associations were unable to provide any data on the annual quantity of vaccine sold from which a more precise rate of vaccination could have been calculated for the period between 1974 and 2004 [24][25][26][27][28][29][30][31][32][33][34].…”
Section: Methodsmentioning
confidence: 99%
“…The Jeryl Lynn and Urabe Am9 strains have been the most popularly used in the world, followed by the Leningrad-Zagreb, Leningrad-3, and Rubini strains. The newer RIT 4385 strain was derived from the Jeryl Lynn strain [21,[72][73][74][75]. Initially, mumps vaccines (panel) were produced as a form of monovalent vaccine, and mumps vaccines are currently manufactured as a component of the trivalent measles-mumps-rubella (MMR) vaccine worldwide [73].…”
Section: General Considerationsmentioning
confidence: 99%
“…Initially, mumps vaccines (panel) were produced as a form of monovalent vaccine, and mumps vaccines are currently manufactured as a component of the trivalent measles-mumps-rubella (MMR) vaccine worldwide [73]. At least five known combination MMR vaccines have been developed since the 1960s worldwide (Table 2) [72][73][74][75][76]. To date, the MMR vaccine has been used in more than 120 countries worldwide [2,76].…”
Section: General Considerationsmentioning
confidence: 99%
“…In Germany, these vaccines have been used since 1976. During the last 16 years, about 5.5 million vaccines with live attenuated virus of the Jeryll-Lynn strain (Behringwerke AG, D-3550 Marburg/Lahn, FRG) have been distributed [2], In the same period, four certain cases of vaccination-related mumps orchitis have been published [3],…”
Section: Introductionmentioning
confidence: 99%